Cargando…

Monitoring the transition of patients on biologics in rheumatoid arthritis: Consensus guidance for pharmacists

BACKGROUND: Recent approvals for novel agents such as the small molecule Janus kinase inhibitors (JAKi), combined with the advent of biosimilars has widened the gamut of available therapeutic options in the treatment of rheumatoid arthritis (RA). This combined with the introduction of mandatory non-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choquette, Denis, Chan, Jonathan, Bardi, Mohammad, Whiskin, Carolyn, Torani, Gabriel, Smith, Brennan K., Sihota, Aaron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centro de Investigaciones y Publicaciones Farmaceuticas 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455126/ https://www.ncbi.nlm.nih.gov/pubmed/34621449 http://dx.doi.org/10.18549/PharmPract.2021.3.2377

Ejemplares similares

SARS-CoV-2 rapid diagnostic testing: Canadian consensus guidance for pharmacists
por: Sihota, Aaron, et al.
Publicado: (2023)

Canadian national consensus guidelines for naloxone prescribing by pharmacists
por: Tsuyuki, Ross T., et al.
Publicado: (2020)

Management of rheumatoid arthritis: summary of NICE guidance
por: Deighton, Chris, et al.
Publicado: (2009)

Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry
por: Choquette, Denis, et al.
Publicado: (2019)

Discontinuation of tofacitinib and TNF inhibitors in patients with rheumatoid arthritis: analysis of pooled data from two registries in Canada
por: Movahedi, Mohammad, et al.
Publicado: (2023)

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
por: Buch, Maya H, et al.
Publicado: (2011)

Consensus Decision Models for Biologics in Rheumatoid and Psoriatic Arthritis: Recommendations of a Multidisciplinary Working Party
por: Madan, Jason, et al.
Publicado: (2015)

Trends of rheumatoid arthritis monitorization in Romania
por: Mogoşan, C, et al.
Publicado: (2010)

Monitoring diabetes in patients with and without rheumatoid arthritis: a Medicare study
por: Bartels, Christie M, et al.
Publicado: (2012)

Aspects of exercise with person-centred guidance influencing the transition to independent exercise: a qualitative interview study among older adults with rheumatoid arthritis
por: Lange, Elvira, et al.
Publicado: (2019)

Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis
por: Mulleman, Denis, et al.
Publicado: (2009)

Management of rheumatoid arthritis: consensus recommendations from the Hong Kong Society of Rheumatology
por: Mok, Chi Chiu, et al.
Publicado: (2010)

Patient and Healthcare Professionals Preference for Brenzys vs. Enbrel Autoinjector for Rheumatoid Arthritis: A Randomized Crossover Simulated-Use Study
por: Egeth, Marc, et al.
Publicado: (2017)

Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
por: González-Álvaro, Isidoro, et al.
Publicado: (2015)

The monocyte-to-osteoclast transition in rheumatoid arthritis: Recent findings
por: Iwamoto, Naoki, et al.
Publicado: (2022)

Dietary Guidance for Cardiovascular Health: Consensus and Controversies
por: Pietri, Panagiota
Publicado: (2023)

Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study
por: Haraoui, Boulos, et al.
Publicado: (2022)

International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update
por: Narayanaswami, Pushpa, et al.
Publicado: (2021)

Recent developments in the immunobiology of rheumatoid arthritis
por: Andersson, Anna K, et al.
Publicado: (2008)

The potential value of blood monitoring of biologic drugs used in the treatment of rheumatoid arthritis
por: Perry, Martin, et al.
Publicado: (2020)

Pharmacists as facilitators of pharmacogenomic guidance for antidepressant drug selection and dosing
por: Bishop, Jeffrey R.
Publicado: (2021)

Important features of retail shoes for women with rheumatoid arthritis: A Delphi consensus survey
por: Tehan, Peta Ellen, et al.
Publicado: (2019)

Exploring the treatment burden of disease-modifying anti-rheumatic drug monitoring in people with rheumatoid arthritis
por: Ryan, Sarah, et al.
Publicado: (2023)

Concurrent validation of activity monitors in patients with rheumatoid arthritis()
por: Backhouse, Michael R., et al.
Publicado: (2013)

Laboratory Standards in Diagnosis and Therapy Monitoring of Rheumatoid Arthritis
por: Tešija-Kuna, Andrea
Publicado: (2006)

Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDs
por: Rigby, William F. C., et al.
Publicado: (2017)

Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry
por: Rahman, Proton, et al.
Publicado: (2020)

Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada
por: Weijers, Laure, et al.
Publicado: (2017)

Quality Indicators for Evaluating the Health Care of Patients with Rheumatoid Arthritis: a Korean Expert Consensus
por: Seo, Mi Ryoung, et al.
Publicado: (2021)

Openreuma Consensus on the role of nursing in the care of patients with rheumatoid arthritis and diffuse interstitial lung disease
por: Cano García, Laura, et al.
Publicado: (2023)

Management of type 2 diabetes with oral semaglutide: Practical guidance for pharmacists
por: Kane, Michael P, et al.
Publicado: (2020)

Intravitreal Corticosteroid Implantation in Diabetic Macular Edema: Updated European Consensus Guidance on Monitoring and Managing Intraocular Pressure
por: Goñi, Francisco J., et al.
Publicado: (2022)

Controversy and consensus on a clinical pharmacist in primary care in the Netherlands
por: Hazen, Ankie C. M., et al.
Publicado: (2016)

Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study
por: Courvoisier, D.S., et al.
Publicado: (2016)

Biologic monotherapy in the treatment of rheumatoid arthritis
por: Detert, Jacqueline, et al.
Publicado: (2015)

Biologicals in rheumatoid arthritis: current and future
por: Avci, Ali Berkant, et al.
Publicado: (2015)

Treatment with Biologicals in Rheumatoid Arthritis: An Overview
por: Rein, Philipp, et al.
Publicado: (2017)

Identification of a transitional fibroblast function in very early rheumatoid arthritis
por: Filer, Andrew, et al.
Publicado: (2017)

Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2018)

International consensus guidance for management of myasthenia gravis: Executive summary
por: Sanders, Donald B., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8m0ip03lfgvnpjn7v9f5n3egck